The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | ESMO 2018 Congress
Videos  >  

Identifying Unique Antigen Qualities in Long-Term Pancreatic Cancer Survivors

Vinod P. Balachandran, MD
Published Online:4:03 PM, Thu November 16, 2017

Vinod P. Balachandran, MD, Surgical Oncologist, Memorial Sloan Kettering Cancer Center, discusses an analysis to determine the unique antigen qualities of long-term survivors of pancreatic cancer during The Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.